[1]
“COMMON HUB GENES AND DRUG CANDIDATES FOR DIABETIC KIDNEY DISEASE AND NON-ALCOHOLIC FATTY LIVER DISEASE: A COMPREHENSIVE BIOINFORMATIC STUDY”, Int. J. Pharm. Sci. Drug Res., vol. 16, no. 1, pp. 102–109, Jan. 2024, doi: 10.25004/IJPSDR.2024.160114.